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Recruitment of pregnant women in labour to clinical trials poses particular challenges. Interpretation of regulation
lacks consistency or clarity and variation occurs as to the training required by clinicians to safely contribute to the
conduct of intrapartum studies. The Royal College of Obstetricians and Gynaecologists Intrapartum Clinical Study
Group initiated the development of a pragmatic, proportionate and standardised toolkit for training clinical staff
that complies with both regulatory and clinician requirements and has been peer-reviewed. This approach may be
useful to researchers in acute care settings that necessitate the integration of research, routine clinical practice and
compliance with regulation.
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Background
Over-regulation of clinical trials has been well docu-
mented as hindering the delivery of research [1,2]
and extends to the training required by clinical
(non-research) staff undertaking consent and recruit-
ment processes during their routine practice. This
can present particular challenges as uncertainty may
exist for researchers regarding what training is ne-
cessary to uphold the principles of Good Clinical
Practice (GCP), what is practical in the context of
clinical workload, and what is deemed to be ‘suffi-
cient’ training by sponsors, host organisations and
regulators.
Variations in training requirements for clinicians were
identified as part of the High or Low Dose Syntocinon
(HOLDS) pilot study [3]. This was a pilot for a trial
where eligible women were in delayed labour and could
be identified at any time of day; recruitment needed to
occur within a short window period, so to maximize re-
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reproduction in any medium, provided the orWhile standard study-specific training was developed by
the Trial Management Group for use at the collaborating
sites, whether clinicians were permitted to recruit women
in labour over the 24-hour period varied; this was decided
by the local Research and Development Departments and
hinged on the amount of training they felt was required to
undertake predefined research tasks, such as taking
consent in labour. Some adopted a pragmatic approach
whereby clinically experienced staff who had received
study-specific training (including tailored Good Clinical
Practice (GCP) and consent training), could recruit wo-
men over the 24-hour period. Others stipulated that
only research-experienced staff were able to recruit
and that to be deemed such, they must have under-
taken an approved GCP course, which is usually a
day in length. At these sites it was not feasible for all
clinicians on Delivery Suite (usually numbering in ex-
cess of 100 clinical staff ) to receive such training;
recruitment was therefore restricted to office hours,
which not only limited the numbers of women re-
cruited, but also meant that for clinical staff there
was a clear division between research and practice.
Whilst United Kingdom (UK) legislation indicates that
everyone involved in conducting a trial should be quali-
fied by education, training and experience to perform
their respective tasks [4], no guidance on the contentl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ments and clinical needs. Discussions within the Royal College
of Obstetricians and Gynaecologists (RCOG) Intrapartum
Clinical Study Group identified the need to define suitable
training that should enable clinicians to safely contribute to
the conduct of intrapartum research studies. This led to the
development of a training toolkit in collaboration with the
National Institute for Health Research (NIHR) Clinical
Research Network GCP facilitators. This training toolkit is
available at http://www.bmfms.org.uk/News/Intrapartum-
CSG-develop-research-toolkit-/c-1-1-123.
Contents of the toolkit
The materials within the toolkit promote an awareness
of GCP, in particular, consent and safety procedures,
whilst acknowledging that training should be propor-
tionate and tailored to the role of the clinician in the
study. It does not replace the need for more detailed
GCP training as applicable to Principal Investigators or
other research staff who will provide local research ex-
pertise within a site.
The toolkit highlights the need for chief investigators
(CIs) and principal investigators (PIs) to consider the du-
ties and tasks that may be undertaken by clinical staff
during routine intrapartum care (for example, checking
eligibility, receiving consent as part of an ongoing pro-
cess, study specific interventions or data collection).The
toolkit provides appropriate study specific training in ac-
cordance with the principles of GCP. Standard training
materials are approved by the sponsor, in consultation
with collaborators, and would not be altered by sites.
The toolkit includes: a PowerPoint presentation tem-
plate (28 slides into which study-specific information is
added, and which includes quick questions to check un-
derstanding and encourage debate); Guidance Notes to
support the use of the presentation template; and a
Template Training File (word document template for a
variety of study-specific reference materials).
The content of the GCP training slides informs clini-
cians that these are the fundamental standards that un-
derpin clinical research to ensure the safety of research
participants and the integrity of the data. These standards
stress that the study must be conducted in compliance
with the protocol that has received regulatory and local
hospital approval. The training reminds clinicians of their
responsibility to ensure the safety and wellbeing of re-
search participants, and that, as in clinical practice, the cli-
nicians should not undertake any tasks for which they
have not been trained and are unwilling to undertake.
Consent is endorsed as being a continuous process.
The slides outline the principles of consent in research
and the documentation of this process. They further de-
tail the advice from the RCOG regarding the timing of
information for women depending on the frequency ofthe condition being researched [5]. The toolkit reiterates
that those receiving consent should do so in their nor-
mal practice, be familiar with the study, be able to an-
swer any questions the women may have and sign to
confirm they have received training. The training toolkit
also includes the importance of documenting the con-
sent process and of safety reporting; study-specific detail
can be added to the slide templates.
Conclusions
This initiative has resulted in a pragmatic, proportionate
and standardised approach to study-specific training
which fulfills both regulatory requirements and the needs
of clinical staff and facilitates recruitment. It enables intra-
partum research to be embedded in clinical practice and
provides a useful template for researchers in other acute
clinical settings such as critical care.
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